Copper Transporters and Cisplatin Resistance in Ovarian Cancer Cells
Author Information
Author(s): Kalayda Ganna V, Wagner Christina H, Buß Irina, Reedijk Jan, Jaehde Ulrich
Primary Institution: Department of Clinical Pharmacy, Institute of Pharmacy, University of Bonn
Hypothesis
The study aims to assess the relevance of subcellular localization of copper efflux transporters ATP7A and ATP7B for acquired cisplatin resistance in ovarian carcinoma cells.
Conclusion
Alterations in the subcellular localization of copper transport proteins may contribute to cisplatin resistance in ovarian cancer cells.
Supporting Evidence
- Sensitive cells showed ATP7A and ATP7B mainly localized in the trans-Golgi network.
- In resistant cells, ATP7A and ATP7B were found in peripherally located vesicles.
- Altered localization may prevent cisplatin from binding to DNA, contributing to resistance.
- Changes in protein localization could serve as markers for cisplatin resistance.
Takeaway
This study found that the way certain proteins are located inside cancer cells can affect how well the cells respond to a common cancer drug called cisplatin.
Methodology
The study used confocal fluorescence microscopy and MTT-based assays to investigate the localization and cytotoxicity of cisplatin and its fluorescent analogue in sensitive and resistant ovarian carcinoma cell lines.
Limitations
The study did not explore the effects of inhibitors of protein synthesis on the localization of ATP7A and ATP7B.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website